Johannes Gutenberg University of Mainz's cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.

The underwriters for Karolinska Institute spinout Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.

After a two-year stint with Allied Minds, Simon Davidson has moved back to In-Q-Tel as a managing partner.

Qorvo has purchased a portfolio company, radio frequency technology developer Cavendish Kinetics, which was spun out of Cambridge two decades ago.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from OSI and GlaxoSmithKline’s SR One.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

EPFL-backed Foundation for Technology Innovation has appointed David Kappeler as director and head of investments.

Founded from University of Surrey's Space Centre, iKinema was bought by Apple in a move seemingly aligned with the corporate's foray into virtual and augmented reality.

Quentin Compton-Bishop has resigned as CEO of Warwick Ventures, but said he would continue to be involved in university venturing.